AFT Pharmaceuticals Limited (AFP.AX)
AFT Pharmaceuticals Limited operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Auckland, AUK, NZ. The stock last traded at $3.87, up 0.26% on the session, giving a market capitalisation of $405.8M. Its beta of 0.42 implies it has historically moved less than the broad market.
AFT Pharmaceuticals Limited engages in the complete lifecycle of pharmaceutical products, from their initial development and licensing to their distribution and ultimate sale. The company's reach extends throughout New Zealand, Australia, Asia, and various other international markets. Its extensive product range encompasses treatments for allergies, cold and flu symptoms, ophthalmic conditions, first aid, pain management, digestive health, dermatological concerns, and medicated vitamin supplements. Established in 1997, AFT Pharmaceuticals has its corporate headquarters situated in Auckland, New Zealand.
AFT Pharmaceuticals Limited is most often compared with the following Healthcare names: